These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The Mayo Clinic Histiocytosis Working Group Consensus Statement for the Diagnosis and Evaluation of Adult Patients With Histiocytic Neoplasms: Erdheim-Chester Disease, Langerhans Cell Histiocytosis, and Rosai-Dorfman Disease. Goyal G; Young JR; Koster MJ; Tobin WO; Vassallo R; Ryu JH; Davidge-Pitts CJ; Hurtado MD; Ravindran A; Sartori Valinotti JC; Bennani NN; Shah MV; Rech KL; Go RS; Mayo Clin Proc; 2019 Oct; 94(10):2054-2071. PubMed ID: 31472931 [TBL] [Abstract][Full Text] [Related]
10. Survivorship Issues in Adult Patients With Histiocytic Neoplasms. O'Brien K; Dave R; Shekhar S; Hannah-Shmouni F; Comis LE; Solomon BI; Chen M; Gahl WA; FitzGibbon E; Gochuico BR; Estrada-Veras JI J Natl Compr Canc Netw; 2021 Nov; 19(11):1312-1318. PubMed ID: 34781266 [TBL] [Abstract][Full Text] [Related]
11. Comparison of neuroimaging features of histiocytic neoplasms with central nervous system involvement: a retrospective study of 121 adult patients. Fan X; Liu T; Zhang Z; Sun J; Niu N; Mao C; Wang F; Li J; Zhou D; Cao X; Jin Z; Feng F Eur Radiol; 2023 Nov; 33(11):8031-8042. PubMed ID: 37191919 [TBL] [Abstract][Full Text] [Related]
12. Langerhans Cell Histiocytosis and Other Histiocytic Diseases of the Lung. DeMartino E; Go RS; Vassallo R Clin Chest Med; 2016 Sep; 37(3):421-30. PubMed ID: 27514589 [TBL] [Abstract][Full Text] [Related]
13. How I Diagnose Rosai-Dorfman Disease. Ravindran A; Rech KL Am J Clin Pathol; 2023 Jul; 160(1):1-10. PubMed ID: 37167084 [TBL] [Abstract][Full Text] [Related]
14. Histiocytosis and the nervous system: from diagnosis to targeted therapies. Cohen Aubart F; Idbaih A; Emile JF; Amoura Z; Abdel-Wahab O; Durham BH; Haroche J; Diamond EL Neuro Oncol; 2021 Sep; 23(9):1433-1446. PubMed ID: 33993305 [TBL] [Abstract][Full Text] [Related]
15. Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapy. Friedman JS; Durham BH; Reiner AS; Yabe M; Petrova-Drus K; Dogan A; Pulitzer M; Busam KJ; Francis JH; Rampal RK; Ulaner GA; Reddy R; Yeh R; Hatzoglou V; Lacouture ME; Rotemberg V; Mazor RD; Hershkovitz-Rokah O; Shpilberg O; Goyal G; Go RS; Abeykoon JP; Rech K; Morlote D; Fidai S; Gannamani V; Zia M; Abdel-Wahab O; Panageas KS; Rosenblum MK; Diamond EL Br J Haematol; 2024 Jul; 205(1):127-137. PubMed ID: 38613141 [TBL] [Abstract][Full Text] [Related]
18. [Erdheim-Chester disease and Rosai-Dorfman disease: Pathological, radiological and clinical features of adult non-Langerhans cell histiocytosis]. Bösmüller H; Nann D; Horger M; Fend F Pathologe; 2015 Sep; 36(5):458-66. PubMed ID: 26305142 [TBL] [Abstract][Full Text] [Related]
19. Spumous histiocytic oligoarthritis coexisting with systemic Langerhans' cell histiocytosis: case report and literature review. Aouba A; Larousserie F; Le Guern V; Martin A; Guillevin L Joint Bone Spine; 2009 Dec; 76(6):701-4. PubMed ID: 19640768 [TBL] [Abstract][Full Text] [Related]
20. PU.1 is a useful nuclear marker to distinguish between histiocytosis and histiocyte-rich tumours. Ungureanu IA; Cohen-Aubart F; Héritier S; Haroche J; Donadieu J; Emile JF Histopathology; 2023 Aug; 83(2):320-325. PubMed ID: 37012662 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]